Simplex Trading
PHAS

Simplex Trading’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Simplex Trading’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,317
Closed – – 11066
2022
Q3 		$0 Buy
+3,317
New +$3.38K ﹤0.01% 11365
2022
Q2 		– Sell
-927
Closed -$888 – 11607
2022
Q1 		$1K Sell
927
-10,798
-92% -$17.5K ﹤0.01% 10233
2021
Q4 		$30K Buy
11,725
+11,308
+2,712% +$34.2K ﹤0.01% 7922
2021
Q3 		$1K Sell
417
-100
-19% -$334 ﹤0.01% 9715
2021
Q2 		$1K Buy
+517
New +$1.72K ﹤0.01% 9894
2021
Q1 		– Sell
-6,744
Closed -$27.4K – 10417
2020
Q4 		$22K Buy
+6,744
New +$24.1K ﹤0.01% 6926
2020
Q3 		– Sell
-2,839
Closed -$13K – 8789
2020
Q2 		$13K Buy
+2,839
New +$12.6K ﹤0.01% 6519

Other funds holding PHAS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Simplex Trading's PHAS Position: Q4 2022 in Review

Simplex Trading sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q4 2022, closing a stake of 3,317 shares.

Simplex Trading first reported a position in PHAS in Q2 2020 and held it in 7 quarters. The position peaked at $30K in Q4 2021. 5 funds tracked by Wall St. Rank hold PHAS as of Q4 2022.

  • Simplex Trading reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 3,317 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
  • Simplex Trading first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Simplex Trading's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $30K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.